A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults with Non-Small Cell Lung Cancer
Imugene Limited
Imugene Limited
Coherent Biopharma (Hefei) Co., Ltd.
University Hospital, Brest
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Kalbe International Pte. Ltd
Suzhou Genhouse Bio Co., Ltd.
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Chang Gung Memorial Hospital
Henan Cancer Hospital
Region Örebro County
The First Affiliated Hospital of Dalian Medical University
European Institute of Oncology
Henan Cancer Hospital
Institut Paoli-Calmettes
Assistance Publique Hopitaux De Marseille
University Hospital, Antwerp
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Nantes University Hospital
The First Affiliated Hospital of Xinxiang Medical College
Centre Hospitalier Universitaire Vaudois
Chung Shan Medical University
China-Japan Friendship Hospital
Guangdong Association of Clinical Trials
Henan Cancer Hospital
Universitair Ziekenhuis Brussel
Taoyuan General Hospital
Sichuan Cancer Hospital and Research Institute
National Taipei University of Nursing and Health Sciences
Zhejiang University
Palobiofarma SL
Centre Hospitalier Universitaire de Liege
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Hacettepe University
University of Louisville
Central TB Research Institute
The First Affiliated Hospital of Guangzhou Medical University
Azienda Sanitaria-Universitaria Integrata di Udine
Regina Elena Cancer Institute
Hospices Civils de Lyon
Aurigene Discovery Technologies Limited
University Hospital Ostrava
Assistance Publique - Hôpitaux de Paris
RS Oncology LLC
University of Turin, Italy
University Hospital, Essen
The First Affiliated Hospital with Nanjing Medical University
Fujian Cancer Hospital
Hummingbird Diagnostics
Radiotherapy Oncology Centre "Santa Maria" Hospital